| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $579.8M | +11.4% |
| R&D Expense | $90.5M | +19.1% |
| SG&A Expense | $304.8M | +51.9% |
| Operating Income | $86.0M | -50.5% |
| Interest Expense | $19.7M | +1.3% |
| Pre-tax Income | $73.2M | -56.6% |
| Income Tax | $19.8M | -52.6% |
| Net Income | $53.4M | -57.9% |
| EPS (Basic) | $1.01 |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $203.4M | -29.5% |
| Short-term Investments | $136.2M | +1.8% |
| Accounts Receivable | $148.9M | +5.7% |
| Inventory | $86.0M | +77.9% |
| Current Assets | $601.6M | -4.6% |
| Total Assets | $1.69B | +12.3% |
| Current Liabilities | $315.4M | +28.7% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $127.1M | -8.1% |
| Investing Cash Flow | -$81.9M | -136.1% |
| Financing Cash Flow | -$130.4M | -3764.5% |
| -58.1% |
| EPS (Diluted) | $0.98 | -58.5% |
| Total Liabilities |
| $873.3M |
| +15.0% |
| Stockholders' Equity | $815.9M | +9.5% |